ORION OYJ/ADR (OTCMKTS:ORINY) – Research analysts at Jefferies Financial Group lowered their FY2020 earnings per share estimates for ORION OYJ/ADR in a note issued to investors on Tuesday, October 30th. Jefferies Financial Group analyst J. Vane-Tempest now forecasts that the company will post earnings per share of $0.79 for the year, down from their prior estimate of $0.81.
Separately, Zacks Investment Research cut ORION OYJ/ADR from a “hold” rating to a “strong sell” rating in a research note on Tuesday, July 17th.
Shares of OTCMKTS ORINY opened at $18.24 on Thursday. The company has a market capitalization of $5.15 billion, a P/E ratio of 20.04 and a beta of 0.51. ORION OYJ/ADR has a 52 week low of $15.00 and a 52 week high of $21.17.
ORION OYJ/ADR Company Profile
Orion Oyj engages in the development and manufacture of pharmaceuticals, active pharmaceutical ingredients (APIs), and diagnostic tests worldwide. The company operates in two segments, Pharmaceuticals and Diagnostics. The Pharmaceuticals segment develops, manufactures, and markets pharmaceuticals and APIs.
Further Reading: Why is the conference call important?
Receive News & Ratings for ORION OYJ/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ORION OYJ/ADR and related companies with MarketBeat.com's FREE daily email newsletter.